Somu Subramaniam invests across both deep-tech hardware and life sciences, backing companies like satellite propulsion startup Phase Four and urban transit company Glydways alongside therapeutics and biosciences firms, and he tends to stay involved as a board member through to exit. Before venture capital, he was a McKinsey director who led its Strategy, Technology, and Healthcare practices and sat on the firm's Investment Committee, and he co-authored McKinsey Quarterly articles on corporate strategy, including "Bringing discipline to strategy" and "Breaking up is good to do."